177 related articles for article (PubMed ID: 23720424)
1. Stromal insulin-like growth factor binding protein 3 (IGFBP3) is elevated in the diseased human prostate and promotes ex vivo fibroblast-to-myofibroblast differentiation.
Sampson N; Zenzmaier C; Heitz M; Hermann M; Plas E; Schäfer G; Klocker H; Berger P
Endocrinology; 2013 Aug; 154(8):2586-99. PubMed ID: 23720424
[TBL] [Abstract][Full Text] [Related]
2. ROS signaling by NOX4 drives fibroblast-to-myofibroblast differentiation in the diseased prostatic stroma.
Sampson N; Koziel R; Zenzmaier C; Bubendorf L; Plas E; Jansen-Dürr P; Berger P
Mol Endocrinol; 2011 Mar; 25(3):503-15. PubMed ID: 21273445
[TBL] [Abstract][Full Text] [Related]
3. Dickkopf-related protein 3 promotes pathogenic stromal remodeling in benign prostatic hyperplasia and prostate cancer.
Zenzmaier C; Sampson N; Plas E; Berger P
Prostate; 2013 Sep; 73(13):1441-52. PubMed ID: 23765731
[TBL] [Abstract][Full Text] [Related]
4. Phosphodiesterase type 5 inhibition reverts prostate fibroblast-to-myofibroblast trans-differentiation.
Zenzmaier C; Kern J; Sampson N; Heitz M; Plas E; Untergasser G; Berger P
Endocrinology; 2012 Nov; 153(11):5546-55. PubMed ID: 22948216
[TBL] [Abstract][Full Text] [Related]
5. Growth regulation of prostatic stromal cells by prostate-specific antigen.
Sutkowski DM; Goode RL; Baniel J; Teater C; Cohen P; McNulty AM; Hsiung HM; Becker GW; Neubauer BL
J Natl Cancer Inst; 1999 Oct; 91(19):1663-9. PubMed ID: 10511594
[TBL] [Abstract][Full Text] [Related]
6. Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation.
Untergasser G; Gander R; Lilg C; Lepperdinger G; Plas E; Berger P
Mech Ageing Dev; 2005 Jan; 126(1):59-69. PubMed ID: 15610763
[TBL] [Abstract][Full Text] [Related]
7. Activators and stimulators of soluble guanylate cyclase counteract myofibroblast differentiation of prostatic and dermal stromal cells.
Zenzmaier C; Kern J; Heitz M; Plas E; Zwerschke W; Mattesich M; Sandner P; Berger P
Exp Cell Res; 2015 Nov; 338(2):162-9. PubMed ID: 26410556
[TBL] [Abstract][Full Text] [Related]
8. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
Tuxhorn JA; Ayala GE; Smith MJ; Smith VC; Dang TD; Rowley DR
Clin Cancer Res; 2002 Sep; 8(9):2912-23. PubMed ID: 12231536
[TBL] [Abstract][Full Text] [Related]
9. DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells.
Le H; Arnold JT; McFann KK; Blackman MR
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E952-60. PubMed ID: 16368782
[TBL] [Abstract][Full Text] [Related]
10. Opposing actions of TGFbeta1 and FGF2 on growth, differentiation and extracellular matrix accumulation in prostatic stromal cells.
Cross NA; Reid SV; Harvey AJ; Jokonya N; Eaton CL
Growth Factors; 2006 Dec; 24(4):233-41. PubMed ID: 17381064
[TBL] [Abstract][Full Text] [Related]
11. Immunolocalization of the keratinocyte growth factor in benign and neoplastic human prostate and its relation to androgen receptor.
Planz B; Aretz HT; Wang Q; Tabatabaei S; Kirley SD; Lin CW; McDougal WS
Prostate; 1999 Dec; 41(4):233-42. PubMed ID: 10544296
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia.
Cohen P; Peehl DM; Baker B; Liu F; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1994 Nov; 79(5):1410-5. PubMed ID: 7525636
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Nox4-dependent ROS signaling attenuates prostate fibroblast activation and abrogates stromal-mediated protumorigenic interactions.
Sampson N; Brunner E; Weber A; Puhr M; Schäfer G; Szyndralewiez C; Klocker H
Int J Cancer; 2018 Jul; 143(2):383-395. PubMed ID: 29441570
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta induces growth inhibition and IGF-binding protein-3 production in prostatic stromal cells: abnormalities in cells cultured from benign prostatic hyperplasia tissues.
Cohen P; Nunn SE; Peehl DM
J Endocrinol; 2000 Feb; 164(2):215-23. PubMed ID: 10657857
[TBL] [Abstract][Full Text] [Related]
15. Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues.
Zhao H; Ramos CF; Brooks JD; Peehl DM
J Cell Physiol; 2007 Jan; 210(1):111-21. PubMed ID: 17044071
[TBL] [Abstract][Full Text] [Related]
16. Elevated epithelial expression of interleukin-8 correlates with myofibroblast reactive stroma in benign prostatic hyperplasia.
Schauer IG; Ressler SJ; Tuxhorn JA; Dang TD; Rowley DR
Urology; 2008 Jul; 72(1):205-13. PubMed ID: 18314176
[TBL] [Abstract][Full Text] [Related]
17. M2a macrophage can rescue proliferation and gene expression of benign prostate hyperplasia epithelial and stroma cells from insulin-like growth factor 1 knockdown.
Qian Q; He W; Liu D; Yin J; Ye L; Chen P; Xu D; Liu J; Li Y; Zeng G; Li M; Wu Z; Zhang Y; Wang X; DiSanto ME; Zhang X
Prostate; 2021 Jun; 81(9):530-542. PubMed ID: 33861464
[TBL] [Abstract][Full Text] [Related]
18. Stromally expressed c-Jun regulates proliferation of prostate epithelial cells.
Li W; Wu CL; Febbo PG; Olumi AF
Am J Pathol; 2007 Oct; 171(4):1189-98. PubMed ID: 17702894
[TBL] [Abstract][Full Text] [Related]
19. Estradiol, progesterone, and transforming growth factor alpha regulate insulin-like growth factor binding protein-3 (IGFBP3) expression in mouse endometrial cells.
Maekawa T; Takeuchi S; Kanayama M; Takahashi S
Zoolog Sci; 2009 Feb; 26(2):131-8. PubMed ID: 19341330
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples.
Gravina GL; Mancini A; Ranieri G; Di Pasquale B; Marampon F; Di Clemente L; Ricevuto E; Festuccia C
Int J Oncol; 2013 Jun; 42(6):2116-22. PubMed ID: 23589051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
